Several studies demonstrated the importance of targeting multiple kinases, such as the combination of ATM and PARP [76] and the synergistic killing effect of GBM cells by combining CHK1 and MEK1/2 inhibition [86]. Here, CHEK1 is linked to glioblastoma.